US closes personal medication import loophole; Europe competitiveness concerns

A US regulatory loophole permitting personal mail-order import of medications will close next month, affecting Americans who rely on cheaper foreign drugs. The change is part of broader regulatory tightening, while European competitiveness in pharma remains a separate concern. The impact on drug prices and access is uncertain.